Coronavirus disease-2019 (COVID-19) is a serious viral infection, which may cause various clinical conditions ranging from mild-to-moderate symptoms to fatal consequences. 1 Rocuronium is a neuromuscular blocking agent (NMBA). It is widely used in general anesthesia and also recommended as an infusion therapy in patients with acute respiratory distress syndrome (ARDS), who require intensive respiratory support. 2 Although fixed and dilated pupils were mentioned in a few case reports, it was considered as not a very frequent side effect of rocuronium. 3,4 In this case report, we presented a patient, who was treated with rocuronium infusion due to the COVID-19 related ARDS and developed bilateral fixed and dilated pupils.
ABS TRACT Coronavirus disease-2019 (COVID-19) is a serious health problem that started in China in December 2019 and spread worldwide as a pandemic. Due to the fact that COVID-19 is a pandemic, it can be associated with many diseases. In particular, high rates of co-infection with other respiratory pathogens, including influenza virus, Legionella pneumophila, Mycoplasma pneumoniae, have been described. Brucellosis is a bacterial zoonosis caused by Brucella spp. that can be transmitted through direct contact with infected animals or ingestion of unpasteurized milk or milk products. Brucellosis is endemic in our country, and is still increasing in people who are engaged in animal husbandry and consuming raw milk or milk products. Clinical findings are of brucellosis similar to COVID-19 infection and diagnosis is difficult. In this presentation, a case diagnosed with brucellosis while being followed up in the intensive care unit due to COVID-19.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.